ES2053732T3 - Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo. - Google Patents

Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.

Info

Publication number
ES2053732T3
ES2053732T3 ES88304359T ES88304359T ES2053732T3 ES 2053732 T3 ES2053732 T3 ES 2053732T3 ES 88304359 T ES88304359 T ES 88304359T ES 88304359 T ES88304359 T ES 88304359T ES 2053732 T3 ES2053732 T3 ES 2053732T3
Authority
ES
Spain
Prior art keywords
turkey
rhinotraqueitis
virus
vaccine
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88304359T
Other languages
English (en)
Inventor
Jane Kathleen Alexandra Cook
Judith A Frazier
Albert Philip Adrian Mockett
Matthew Mckinley Binns
Christine Ann Dolby
Philip Box
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KNOW HOW LICENSORS Ltd
Original Assignee
KNOW HOW LICENSORS Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878712042A external-priority patent/GB8712042D0/en
Priority claimed from GB878720318A external-priority patent/GB8720318D0/en
Application filed by KNOW HOW LICENSORS Ltd filed Critical KNOW HOW LICENSORS Ltd
Application granted granted Critical
Publication of ES2053732T3 publication Critical patent/ES2053732T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

SE OBTIENE UNA CEPA ATENUADA DEL VIRUS DE LA RINOTRAQUEITIS DEL PAVO MEDIANTE PASO ALTERNADO DE CULTIVO EN HUEVO EMBRIONARIO Y ORGANO TRAQUEAL DEL VIRUS DE LA RINOTRAQUEITIS CONTAFIOSA DEL PAVO. LOS PAVOS PUEDEN SER VACUNADOS PARA EVITAR QUE TENGAN LA RINOTRAQUEITIS DEL PAVO Y LOS POLLOS PUEDEN SER VACUNADOSPARA EVITAR QUE TENGAN EL SINDROME DE LA CABEZA HINCHADA.
ES88304359T 1987-05-21 1988-05-13 Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo. Expired - Lifetime ES2053732T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878712042A GB8712042D0 (en) 1987-05-21 1987-05-21 Virus & vaccine
GB878720318A GB8720318D0 (en) 1987-08-28 1987-08-28 Biological preparations

Publications (1)

Publication Number Publication Date
ES2053732T3 true ES2053732T3 (es) 1994-08-01

Family

ID=26292269

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88304359T Expired - Lifetime ES2053732T3 (es) 1987-05-21 1988-05-13 Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.

Country Status (7)

Country Link
US (1) US5069902A (es)
EP (1) EP0292210B1 (es)
CA (1) CA1337266C (es)
DE (1) DE3878982T2 (es)
ES (1) ES2053732T3 (es)
HU (1) HU203674B (es)
IL (1) IL86397A (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2989080B2 (ja) * 1992-12-17 1999-12-13 帝人株式会社 磁気記録媒体用積層ポリエステルフイルム
DE69426051T2 (de) * 1993-07-30 2001-05-10 Akzo Nobel N.V., Arnheim/Arnhem Impfstoff für Geflügel
FR2801607B1 (fr) * 1999-11-26 2001-12-28 Merial Sas Pneumovirus du canard et vaccins correspondants
US6605460B1 (en) * 2000-09-22 2003-08-12 University Of Minnesota Avian pneumovirus vaccine
AR031405A1 (es) * 2000-11-21 2003-09-24 Wyeth Corp Metodos y vacunas para conferir proteccion in ovo contra la rinotraqueitis del pavo
US6977079B2 (en) * 2003-01-17 2005-12-20 Regents Of The University Of Minnesota Avian pneumovirus vaccine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7801060A (nl) * 1977-02-09 1978-08-11 Merck & Co Inc Werkwijze voor het bereiden van een afgezwakt syncytiaal ademhalingsvirus, alsmede prepara- ten en vaccins die dit virus bevatten.
US4122167A (en) * 1977-02-09 1978-10-24 Merck & Co., Inc. Respiratory synctial vaccine
LU79503A1 (fr) * 1977-08-17 1978-11-28 Merck & Co Inc Procede de preparation d'un vaccin syncytial du virus respiratoire
FR2602791B1 (fr) * 1986-08-18 1988-11-10 Ministere Agri Direction Quali Procede de culture du virus de la rhinotracheite infectieuse de la dinde, et vaccin prepare a partir du virus ainsi obtenu

Also Published As

Publication number Publication date
DE3878982T2 (de) 1993-07-22
EP0292210B1 (en) 1993-03-10
US5069902A (en) 1991-12-03
EP0292210A3 (en) 1990-01-24
EP0292210A2 (en) 1988-11-23
HUT50049A (en) 1989-12-28
DE3878982D1 (de) 1993-04-15
HU203674B (en) 1991-09-30
IL86397A (en) 1992-09-06
IL86397A0 (en) 1988-11-15
CA1337266C (en) 1995-10-10

Similar Documents

Publication Publication Date Title
Alexander et al. Experimental assessment of the pathogenicity of eight avian influenza A viruses of H5 subtype for chickens, turkeys, ducks and quail
Pejkovski et al. Immunosuppressive effect of infectious bursal disease virus on vaccination against infectious bronchitis
Anjum Experimental transmission of hydropericardium syndrome and protection against it in commercial broiler chickens
Sharma Embryo vaccination with infectious bursal disease virus alone or in combination with Marek's disease vaccine
Cook et al. A live attenuated turkey rhinotracheitis virus vaccine. 1. Stability of the attenuated strain
Cook et al. A live attenuated turkey rhinotracheitis virus vaccine. 2. The use of the attenuated strain as an experimental vaccine
ES347412A1 (es) Procedimiento para la preparacion de una suspension viral inactivada monovalente o polivalente.
US4302444A (en) Vaccines for immunizing egg-laying birds against Egg Drop disease, preparation of said vaccines, and method of use of said vaccines
Heddleston et al. Fowl cholera: immune response in turkeys
ES373631A1 (es) Procedimiento para la obtencion de una vacuna activa contrala enfermedad de maret.
ES2053732T3 (es) Virus atenuado y vacuna del mismo para empleo contra infecciones de aves causadas por el virus de la rinotraqueitis de pavo.
Klieve et al. Immunity and cross‐protection to nephritis produced by Australian infectious bronchitis viruses used as vaccines
Smithies et al. Two different type A influenza virus infections in turkeys in Wisconsin II. 1968 outbreak
CA2273074C (en) In ovo vaccination against newcastle disease
GB1596653A (en) Vaccine
ES2053477T3 (es) Vacuna viva para enfermedades contagiosas de pollos.
US3331736A (en) Modified laryngotracheitis vaccine
Youn et al. Interference Between Lymphocytic Chorio-meningitis and Rauscher Leukemia in Mice 1, 2
Hearn Jr A variant of Venezuelan equine encephalomyelitis virus attenuated for mice and monkeys
Johnson et al. Field studies with convalescent serum and infectious bursal disease vaccine to control turkey coryza
KR960003606B1 (ko) 가금류의 대장균증 백신
KR890014127A (ko) 생 조합 백신
Bankowski A modified live Newcastle disease virus vaccine.
Oxford et al. Chick embryo lethal orphan (CELO) virus as a possible contaminant of egg-grown virus vaccines
Aitken et al. Observations on the serological and dermal responses of turkeys to a single subcutaneous inoculation of inactivated Newcastle disease vaccine in mineral oil adjuvant

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 292210

Country of ref document: ES